Merilee Raines Ocular Therapeutix, Inc (OCUL) insider trading activity

OCUL Quotes by TradingView

Merilee Raines is Director of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 32,933 shares of OCUL, which is worth approximately $321,755. The most recent transaction as insider was on Jul 24, 2024, when has been sold 12,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.9K
0% 3M change
57.33% 12M change
Total Value Held $321,755

MERILEE RAINES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 24 2024
BUY
Grant, award, or other acquisition
-
12,000 Added 26.71%
32,933 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
12,000 Added 36.44%
20,933 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
8,933 Added 50.0%
8,933 Common Stock

Also insider at

WTS
WATTS WATER TECHNOLOGIES INC Industrials
Director
TMDX
TransMedics Group, Inc. Healthcare
BHE
BENCHMARK ELECTRONICS INC Technology
Director
MR

Merilee Raines

Director
North Andover, MA

Track Institutional and Insider Activities on OCUL

Follow OCULAR THERAPEUTIX, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

News

Receive news related to OCULAR THERAPEUTIX, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OCUL